{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:51:45Z","timestamp":1781635905763,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid dependence, particularly morphine, has been linked to gut microbiota dysbiosis and systemic inflammation, yet the interplay between gut microbial alterations and hepatic inflammatory responses remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fifty male Wistar rats were separated into two groups, one received escalating morphine doses (5 to 30\u00a0mg\/kg over 10 days), while the other acted as a saline control. Fecal samples were collected at baseline, on days 5 and 10 of treatment, and after a 10-day withdrawal. DNA was extracted for qPCR analysis of\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      ,\n                      <jats:italic>Bifidobacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Clostridium<\/jats:italic>\n                      ,\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      , and\n                      <jats:italic>Faecalibacterium<\/jats:italic>\n                      . Liver tissues were examined for inflammatory markers (\n                      <jats:italic>TNF-\u03b1<\/jats:italic>\n                      ,\n                      <jats:italic>IFN-\u03b3<\/jats:italic>\n                      ,\n                      <jats:italic>IL-6<\/jats:italic>\n                      ,\n                      <jats:italic>NF-\u03baB<\/jats:italic>\n                      ) using RT-qPCR after treatment and withdrawal.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significant decline in\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011) and\n                      <jats:italic>Bifidobacterium<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) following morphine treatment, with partial recovery observed after withdrawal (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0009), yet levels remained below baseline. Conversely,\n                      <jats:italic>Clostridium<\/jats:italic>\n                      levels increased significantly during treatment (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0001), persisting at elevated levels post-withdrawal (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0001).\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      and\n                      <jats:italic>Faecalibacterium<\/jats:italic>\n                      also exhibited decreased abundances during morphine treatment (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.00009), with limited recovery thereafter (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.00008). Hepatic analysis revealed elevated levels of\n                      <jats:italic>TNF-\u03b1<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001),\n                      <jats:italic>IL-6<\/jats:italic>\n                      (\n                      <jats:italic>P\u2009=<\/jats:italic>\n                      \u20090.005), and\n                      <jats:italic>NF-\u03baB<\/jats:italic>\n                      (\n                      <jats:italic>P\u2009=<\/jats:italic>\n                      \u20090.41), alongside a significant reduction in\n                      <jats:italic>IFN-\u03b3<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) expression in the morphine group compared to controls. After withdrawal,\n                      <jats:italic>TNF-\u03b1<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and\n                      <jats:italic>IFN-\u03b3<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004) levels decreased, while\n                      <jats:italic>NF-\u03baB<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) and\n                      <jats:italic>IL-6<\/jats:italic>\n                      (\n                      <jats:italic>P\u2009=<\/jats:italic>\n                      \u20090.4(remained elevated, indicating persistent inflammatory responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Morphine causes lasting gut dysbiosis and liver inflammation, indicating disruption of the gut-liver axis in opioid dependence. These results emphasize morphine\u2019s impact on gut microbiota and liver health, suggesting significant long-term effects of opioid use. Targeting microbiota modulation and anti-inflammatory approaches may offer therapeutic options for opioid-related conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-026-04669-w","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T03:35:14Z","timestamp":1770608114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiota dysbiosis and hepatic inflammation in morphine dependence and withdrawal: insights from a rat model"],"prefix":"10.1186","volume":"26","author":[{"given":"Shirin","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Sadeghi-Adl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Tarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"4669_CR1","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.25215\/0501.057","volume":"5","author":"J Singh","year":"2017","unstructured":"Singh J, Gupta PK. Drug addiction: current trends and management. Int J Indian Psychol. 2017;5(1):2348\u20135396.","journal-title":"Int J Indian Psychol"},{"key":"4669_CR2","unstructured":"Indunil K. Morphine sulfate: clinical applications and Pharmacological considerations. Uva Clin Lab. 2024;10. https:\/\/www.researchgate.net\/publication\/380287749_Morphine_Sulfate_Clinical_Applications_and_Pharmacological_Considerations"},{"issue":"6","key":"4669_CR3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s11010-023-04810-3","volume":"479","author":"I Badshah","year":"2024","unstructured":"Badshah I, Anwar M, Murtaza B, Khan MI. Molecular mechanisms of morphine tolerance and dependence; novel insights and future perspectives. Mol Cell Biochem. 2024;479(6):1457\u201385.","journal-title":"Mol Cell Biochem"},{"issue":"17","key":"4669_CR4","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.3390\/ijms20174302","volume":"20","author":"J Listos","year":"2019","unstructured":"Listos J, \u0141upina M, Talarek S, Mazur A, Orzelska-G\u00f3rka J, Kotli\u0144ska J. The mechanisms involved in morphine addiction: an overview. Int J Mol Sci. 2019;20(17):4302.","journal-title":"Int J Mol Sci"},{"key":"4669_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0267-1","volume":"15","author":"MC Greene","year":"2018","unstructured":"Greene MC, Kane JC, Khoshnood K, Ventevogel P, Tol WA. Challenges and opportunities for implementation of substance misuse interventions in conflict-affected populations. Harm Reduct J. 2018;15:1\u201310.","journal-title":"Harm Reduct J"},{"issue":"24","key":"4669_CR6","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029","volume":"186","author":"T Che","year":"2023","unstructured":"Che T, Roth BL. Molecular basis of opioid receptor signaling. Cell. 2023;186(24):5203\u201319.","journal-title":"Cell"},{"issue":"6","key":"4669_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/10738584211030493","volume":"28","author":"V Malafoglia","year":"2022","unstructured":"Malafoglia V, Ilari S, Vitiello L, Tenti M, Balzani E, Muscoli C, et al. The interplay between chronic pain, opioids, and the immune system. Neuroscientist. 2022;28(6):613\u201327.","journal-title":"Neuroscientist"},{"issue":"193","key":"4669_CR8","first-page":"38","volume":"30","author":"S Tarashi","year":"2021","unstructured":"Tarashi S, Omrani MD, Moshiri A, Siadat SD. Importance of gut microbiota and epigenetic modifications in maintaining health or diseases. J Mazandaran Univ Med Sci. 2021;30(193):38\u201346.","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"11","key":"4669_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut\u2013liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21(11):719\u201333.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"4669_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/microorganisms11071849","volume":"11","author":"F Fakharian","year":"2023","unstructured":"Fakharian F, Thirugnanam S, Welsh DA, Kim W-K, Rappaport J, Bittinger K, et al. The role of gut dysbiosis in the loss of intestinal immune cell functions and viral pathogenesis. Microorganisms. 2023;11(7):1849.","journal-title":"Microorganisms"},{"issue":"1","key":"4669_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo G. Gut\u2013liver axis in alcoholic liver disease. Gastroenterology. 2015;148(1):30\u20136.","journal-title":"Gastroenterology"},{"issue":"1","key":"4669_CR12","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1038\/s41598-018-21915-8","volume":"8","author":"F Wang","year":"2018","unstructured":"Wang F, Meng J, Zhang L, Johnson T, Chen C, Roy S. Morphine induces changes in the gut Microbiome and metabolome in a morphine dependence model. Sci Rep. 2018;8(1):3596.","journal-title":"Sci Rep"},{"key":"4669_CR13","doi-asserted-by":"publisher","unstructured":"BiK, Lei Y, Kong D, Li Y, Fan X, Luo X et al. Progress in the study of intestinal microbiota involved in morphine tolerance. Heliyon. 2024;10(6): e27187. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27187.","DOI":"10.1016\/j.heliyon.2024.e27187"},{"issue":"4","key":"4669_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tice.2010.06.001","volume":"42","author":"SH Bekheet","year":"2010","unstructured":"Bekheet SH. Morphine sulphate induced histopathological and histochemical changes in the rat liver. Tissue Cell. 2010;42(4):266\u201372.","journal-title":"Tissue Cell"},{"issue":"7","key":"4669_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/gut.2006.105122","volume":"56","author":"D Chakass","year":"2007","unstructured":"Chakass D, Philippe D, Erdual E, Dharancy S, Malapel M, Dubuquoy C, et al. \u00b5-Opioid receptor activation prevents acute hepatic inflammation and cell death. Gut. 2007;56(7):974\u201381.","journal-title":"Gut"},{"issue":"2","key":"4669_CR16","doi-asserted-by":"publisher","first-page":"e1048","DOI":"10.1038\/tp.2017.15","volume":"7","author":"S Leclercq","year":"2017","unstructured":"Leclercq S, de Timary P, Delzenne NM, St\u00e4rkel P. The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Translational Psychiatry. 2017;7(2):e1048\u2013e.","journal-title":"Translational Psychiatry"},{"issue":"3","key":"4669_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1523\/JNEUROSCI.22-03-01034.2002","volume":"22","author":"MM Nieto","year":"2002","unstructured":"Nieto MM, Wilson J, Cupo A, Roques BP, Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a Microdialysis study. J Neurosci. 2002;22(3):1034\u201341.","journal-title":"J Neurosci"},{"key":"4669_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-018-1197-5","volume":"18","author":"Y Janssens","year":"2018","unstructured":"Janssens Y, Nielandt J, Bronselaer A, Debunne N, Verbeke F, Wynendaele E, et al. Disbiome database: linking the Microbiome to disease. BMC Microbiol. 2018;18:1\u20136.","journal-title":"BMC Microbiol"},{"issue":"8","key":"4669_CR19","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/biomedicines10081815","volume":"10","author":"KR Thomas","year":"2022","unstructured":"Thomas KR, Watt J, Wu CMJ, Akinrinoye A, Amjad S, Colvin L, et al. Pain and opioid-induced gut microbial dysbiosis. Biomedicines. 2022;10(8):1815.","journal-title":"Biomedicines"},{"issue":"8","key":"4669_CR20","doi-asserted-by":"publisher","first-page":"e23603","DOI":"10.1096\/fj.202301590RR","volume":"38","author":"KH Muchhala","year":"2024","unstructured":"Muchhala KH, Kallurkar PS, Kang M, Koseli E, Poklis JL, Xu Q, et al. The role of morphine-and fentanyl\u2010induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota\u2010gut\u2010brain axis. FASEB J. 2024;38(8):e23603.","journal-title":"FASEB J"},{"issue":"1","key":"4669_CR21","doi-asserted-by":"publisher","first-page":"2292224","DOI":"10.1080\/19490976.2023.2292224","volume":"16","author":"YF Abu","year":"2024","unstructured":"Abu YF, Singh S, Tao J, Chupikova I, Singh P, Meng J, et al. Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity. Gut Microbes. 2024;16(1):2292224.","journal-title":"Gut Microbes"},{"issue":"6","key":"4669_CR22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/mi.2016.9","volume":"9","author":"S Banerjee","year":"2016","unstructured":"Banerjee S, Sindberg G, Wang F, Meng J, Sharma U, Zhang L, et al. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol. 2016;9(6):1418\u201328.","journal-title":"Mucosal Immunol"},{"issue":"3","key":"4669_CR23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/nu13031018","volume":"13","author":"A Blesl","year":"2021","unstructured":"Blesl A, Stadlbauer V. The gut-liver axis in cholestatic liver diseases. Nutrients. 2021;13(3):1018.","journal-title":"Nutrients"},{"issue":"4","key":"4669_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.femsre.2004.01.003","volume":"28","author":"AL Servin","year":"2004","unstructured":"Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004;28(4):405\u201340.","journal-title":"FEMS Microbiol Rev"},{"issue":"8","key":"4669_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/nu10080988","volume":"10","author":"K Hiippala","year":"2018","unstructured":"Hiippala K, Jouhten H, Ronkainen A, Hartikainen A, Kainulainen V, Jalanka J, et al. The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients. 2018;10(8):988.","journal-title":"Nutrients"},{"issue":"4","key":"4669_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/genes16040403","volume":"16","author":"A Borrego-Ruiz","year":"2025","unstructured":"Borrego-Ruiz A, Borrego JJ. Pharmacogenomic and pharmacomicrobiomic aspects of drugs of abuse. Genes. 2025;16(4):403.","journal-title":"Genes"},{"issue":"12","key":"4669_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","volume":"19","author":"JK Gustafsson","year":"2022","unstructured":"Gustafsson JK, Johansson ME. The role of goblet cells and mucus in intestinal homeostasis. Nat Reviews Gastroenterol Hepatol. 2022;19(12):785\u2013803.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"4669_CR28","doi-asserted-by":"publisher","first-page":"754819","DOI":"10.3389\/fmicb.2021.754819","volume":"12","author":"K Nishiyama","year":"2021","unstructured":"Nishiyama K, Yokoi T, Sugiyama M, Osawa R, Mukai T, Okada N. Roles of the cell surface architecture of bacteroides and bifidobacterium in the gut colonization. Front Microbiol. 2021;12:754819.","journal-title":"Front Microbiol"},{"key":"4669_CR29","unstructured":"Wang F. Temporal modulation of gut Microbiome and metabolome by morphine. University of Minnesota; 2015. https:\/\/conservancy.umn.edu\/items\/d88c2736-5be2-4893-ab22-88b7bbc6f898"},{"issue":"5","key":"4669_CR30","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.fshw.2022.04.002","volume":"11","author":"J Cheng","year":"2022","unstructured":"Cheng J, Hu J, Geng F, Nie S. Bacteroides utilization for dietary polysaccharides and their beneficial effects on gut health. Food Sci Hum Wellness. 2022;11(5):1101\u201310.","journal-title":"Food Sci Hum Wellness"},{"issue":"1","key":"4669_CR31","doi-asserted-by":"publisher","first-page":"1826748","DOI":"10.1080\/19490976.2020.1826748","volume":"12","author":"M Lenoir","year":"2020","unstructured":"Lenoir M, Mart\u00edn R, Torres-Maravilla E, Chadi S, Gonz\u00e1lez-D\u00e1vila P, Sokol H, et al. Butyrate mediates anti-inflammatory effects of Faecalibacterium Prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes. 2020;12(1):1826748.","journal-title":"Gut Microbes"},{"key":"4669_CR32","doi-asserted-by":"publisher","first-page":"588666","DOI":"10.3389\/fmicb.2020.588666","volume":"11","author":"Y Han","year":"2020","unstructured":"Han Y, Zhao Q, Tang C, Li Y, Zhang K, Li F, et al. Butyrate mitigates weanling piglets from lipopolysaccharide-induced colitis by regulating microbiota and energy metabolism of the gut\u2013liver axis. Front Microbiol. 2020;11:588666.","journal-title":"Front Microbiol"},{"key":"4669_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7007-11-61","volume":"11","author":"L Wrzosek","year":"2013","unstructured":"Wrzosek L, Miquel S, Noordine M-L, Bouet S, Chevalier-Curt MJ, Robert V, et al. Bacteroides Thetaiotaomicron and Faecalibacterium Prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:1\u201313.","journal-title":"BMC Biol"},{"issue":"6141","key":"4669_CR34","doi-asserted-by":"publisher","first-page":"1237439","DOI":"10.1126\/science.1237439","volume":"341","author":"JJ Faith","year":"2013","unstructured":"Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439.","journal-title":"Science"},{"issue":"1","key":"4669_CR35","doi-asserted-by":"publisher","first-page":"2178797","DOI":"10.1080\/19490976.2023.2178797","volume":"15","author":"L Grieneisen","year":"2023","unstructured":"Grieneisen L, Blekhman R, Archie E. How longitudinal data can contribute to our Understanding of host genetic effects on the gut Microbiome. Gut Microbes. 2023;15(1):2178797.","journal-title":"Gut Microbes"},{"issue":"1","key":"4669_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41522-022-00352-6","volume":"8","author":"S Anand","year":"2022","unstructured":"Anand S, Mande SS. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. Npj Biofilms Microbiomes. 2022;8(1):89.","journal-title":"Npj Biofilms Microbiomes"},{"issue":"1","key":"4669_CR37","doi-asserted-by":"publisher","first-page":"e54040","DOI":"10.1371\/journal.pone.0054040","volume":"8","author":"J Meng","year":"2013","unstructured":"Meng J, Yu H, Ma J, Wang J, Banerjee S, Charboneau R, et al. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS ONE. 2013;8(1):e54040.","journal-title":"PLoS ONE"},{"issue":"5","key":"4669_CR38","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1007\/s10787-023-01327-5","volume":"31","author":"KM Ibrahim","year":"2023","unstructured":"Ibrahim KM, Ahmed HI, Ramadan L, Balah A. A low dose of Naloxone mitigates autoimmune hepatitis by regulating TLR4\/NF-\u03baB and Nrf2\/HO-1 signaling pathways. Inflammopharmacology. 2023;31(5):2467\u201378.","journal-title":"Inflammopharmacology"},{"issue":"8","key":"4669_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0192-0561(00)00023-0","volume":"22","author":"R Pacifici","year":"2000","unstructured":"Pacifici R, di Carlo S, Bacosi A, Pichini S, Zuccaro P. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int J Immunopharmacol. 2000;22(8):603\u201314.","journal-title":"Int J Immunopharmacol"},{"key":"4669_CR40","doi-asserted-by":"publisher","first-page":"e14053","DOI":"10.7717\/peerj.14053","volume":"10","author":"Y Yu","year":"2022","unstructured":"Yu Y, Yue Z, Xu M, Zhang M, Shen X, Ma Z, et al. Macrophages play a key role in tissue repair and regeneration. PeerJ. 2022;10:e14053.","journal-title":"PeerJ"},{"issue":"1","key":"4669_CR41","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/srep01977","volume":"3","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Meng J, Das S, Krishnan A, Haworth J, Charboneau R, et al. Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a. Sci Rep. 2013;3(1):1977.","journal-title":"Sci Rep"},{"issue":"7","key":"4669_CR42","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/bcp.15281","volume":"88","author":"C Abdel Shaheed","year":"2022","unstructured":"Abdel Shaheed C, Beardsley J, Day RO, McLachlan AJ. Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: mechanisms and relevance to infection. Br J Clin Pharmacol. 2022;88(7):3114\u201331.","journal-title":"Br J Clin Pharmacol"},{"key":"4669_CR43","doi-asserted-by":"publisher","unstructured":"FerdosnejadK, Zamani MS, Rahimlou B, Tarashi S. Morphine\u2019s Effects on the Gut-brain Axis, Inflammation, Behavior, and Microbiome Modulation in Rats. Immunoregulation. 2024;7(10). https:\/\/doi.org\/10.32598\/IMMUNOREGULATION.7.10.","DOI":"10.32598\/IMMUNOREGULATION.7.10"},{"key":"4669_CR44","doi-asserted-by":"publisher","first-page":"594150","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2021","unstructured":"Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2021;11:594150.","journal-title":"Front Immunol"},{"issue":"2","key":"4669_CR45","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.4110\/in.2020.20.e15","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Vitetta L. The role of butyrate in attenuating pathobiont-induced hyperinflammation. Immune Netw. 2020;20(2):e15.","journal-title":"Immune Netw"},{"key":"4669_CR46","unstructured":"Kelschenbach J. The effects of morphine withdrawal on immune functioning. University of Minnesota; 2006. https:\/\/www.proquest.com\/openview\/a4b5a46df2c6f9d5363844061f8af83b\/1?cbl=18750&diss=y&pq-origsite=gscholar"},{"issue":"3","key":"4669_CR47","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s12035-022-03144-3","volume":"60","author":"S Ahmadi","year":"2023","unstructured":"Ahmadi S, Mohammadi Talvar S, Masoudi K, Zobeiri M. Repeated use of morphine induces anxiety by affecting a Proinflammatory cytokine signaling pathway in the prefrontal cortex in rats. Mol Neurobiol. 2023;60(3):1425\u201339.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"4669_CR48","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41590-023-01453-w","volume":"24","author":"AM Gocher-Demske","year":"2023","unstructured":"Gocher-Demske AM, Cui J, Szymczak-Workman AL, Vignali KM, Latini JN, Pieklo GP, et al. IFN\u03b3-induction of TH1-like regulatory T cells controls antiviral responses. Nat Immunol. 2023;24(5):841\u201354.","journal-title":"Nat Immunol"},{"issue":"1","key":"4669_CR49","doi-asserted-by":"publisher","first-page":"1206914","DOI":"10.1155\/2022\/1206914","volume":"2022","author":"N Molavi","year":"2022","unstructured":"Molavi N, Rasouli-Azad M, Mirzaei H, Matini AH, Banafshe HR, Valiollahzadeh M, et al. The effects of probiotic supplementation on opioid-related disorder in patients under methadone maintenance treatment programs. Int J Clin Pract. 2022;2022(1):1206914.","journal-title":"Int J Clin Pract"},{"key":"4669_CR50","doi-asserted-by":"publisher","unstructured":"RogersTJ, Roy S. The role of opioid receptors in immune system function. Front. Immunol. 2022;12:832292. https:\/\/doi.org\/10.3389\/fimmu.2021.832292.","DOI":"10.3389\/fimmu.2021.832292"},{"key":"4669_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11481-006-9019-1","volume":"1","author":"TK Eisenstein","year":"2006","unstructured":"Eisenstein TK, Rahim RT, Feng P, Thingalaya NK, Meissler JJ. Effects of opioid tolerance and withdrawal on the immune system. J Neuroimmune Pharmacol. 2006;1:237\u201349.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"4669_CR52","doi-asserted-by":"publisher","first-page":"2464942","DOI":"10.1080\/19490976.2025.2464942","volume":"17","author":"S Singh","year":"2025","unstructured":"Singh S, Abu Y, Antoine D, Gomez D, Tao J, Truitt B, et al. Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure. Gut Microbes. 2025;17(1):2464942.","journal-title":"Gut Microbes"},{"issue":"9","key":"4669_CR53","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","volume":"24","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhang M, Wang Y, Dorfman RG, Liu H, Yu T, et al. Faecalibacterium Prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm Bowel Dis. 2018;24(9):1926\u201340.","journal-title":"Inflamm Bowel Dis"},{"key":"4669_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc8907","volume":"14","author":"S Nseir","year":"2010","unstructured":"Nseir S, Makris D, Mathieu D, Durocher A, Marquette C-H. Intensive care unit-acquired infection as a side effect of sedation. Crit Care. 2010;14:1\u201316.","journal-title":"Crit Care"},{"issue":"1","key":"4669_CR55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40200-023-01368-1","volume":"23","author":"S Mehranfar","year":"2024","unstructured":"Mehranfar S, Tarashi S, Hajishizari S, Badi SA, Yekaninejad MS, Clark CC, et al. The association between gut microbiota and resting metabolic rate in overweight\/obese women: a case\u2013control study. J Diabetes Metabolic Disorders. 2024;23(1):931\u201341.","journal-title":"J Diabetes Metabolic Disorders"},{"key":"4669_CR56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fphys.2012.00496","volume":"3","author":"K-A L\u00ea","year":"2013","unstructured":"L\u00ea K-A, Li Y, Xu X, Yang W, Liu T, Zhao X, et al. Alterations in fecal Lactobacillus and bifidobacterium species in type 2 diabetic patients in Southern China population. Front Physiol. 2013;3:496.","journal-title":"Front Physiol"},{"issue":"12","key":"4669_CR57","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1128\/AEM.00380-09","volume":"75","author":"I Mart\u00ednez","year":"2009","unstructured":"Mart\u00ednez I, Wallace G, Zhang C, Legge R, Benson AK, Carr TP, et al. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol. 2009;75(12):4175\u201384.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"4669_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0378-1097(03)00296-9","volume":"222","author":"C Liu","year":"2003","unstructured":"Liu C, Song Y, McTeague M, Vu AW, Wexler H, Finegold SM. Rapid identification of the species of the bacteroides fragilis group by multiplex PCR assays using group-and species-specific primers. FEMS Microbiol Lett. 2003;222(1):9\u201316.","journal-title":"FEMS Microbiol Lett"},{"issue":"suppl2","key":"4669_CR59","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1093\/cid\/cis338","volume":"55","author":"TJ Louie","year":"2012","unstructured":"Louie TJ, Cannon K, Byrne B, Emery J, Ward L, Eyben M, et al. Fidaxomicin preserves the intestinal Microbiome during and after treatment of clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis. 2012;55(suppl2):S132\u201342.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04669-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04669-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04669-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:14Z","timestamp":1781632454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04669-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4669"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04669-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study\u2019s protocols and procedures received approval from the Animal Ethics Committee of the Research and Ethics Committee of the Islamic Azad University of Medical Sciences in Tehran, Iran (Approval number: IR.IAU.PS.REC.1403.279). All experiments were conducted in accordance with ethical guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}